Financial Gravity Asset Management, Inc. Cellectis S.A. Transaction History

Financial Gravity Asset Management, Inc.

$400 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.41 - $3.09 $21 - $27	-9 Reduced 90.0%	1 $3,000
Q4 2023 Jun 26, 2024	BUY	$0.97 - $3.55 $8 - $31	9 Added 900.0%	10 $32,000
Q3 2023 Nov 15, 2023	BUY	$1.58 - $2.86 $12 - $22	8 Added 400.0%	10 $0
Q4 2022 Feb 15, 2023	SELL	$1.85 - $2.6 $11 - $15	-6 Reduced 75.0%	2 $2,000
Q3 2022 Nov 03, 2022	SELL	$2.29 - $4.08 $9 - $16	-4 Reduced 33.33%	8 $24,000
Q2 2022 Aug 05, 2022	SELL	$2.39 - $4.93 $19 - $39	-8 Reduced 40.0%	12 $30,000
Q1 2022 May 13, 2022	SELL	$3.45 - $8.77 $814 - $2,069	-236 Reduced 92.19%	20 $48,000
Q4 2021 Feb 11, 2022	SELL	$8.01 - $12.84 $280 - $449	-35 Reduced 12.03%	256 $2.77 Million
Q3 2021 Nov 12, 2021	BUY	$11.94 - $16.09 $847 - $1,142	71 Added 32.27%	291 $13,000
Q2 2021 Aug 11, 2021	SELL	$14.36 - $20.93 $2,441 - $3,558	-170 Reduced 43.59%	220 $15,000
Q1 2021 May 17, 2021	BUY	$18.19 - $33.25 $54 - $99	3 Added 0.78%	390 $7.89 Million
Q4 2020 Feb 16, 2021	BUY	$15.87 - $31.64 $6,141 - $12,244	387 New	387 $10,000
Q2 2020 Aug 13, 2020	SELL	$8.21 - $21.02 $10,295 - $26,359	-1,254 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$7.81 - $18.82 $5,568 - $13,418	-713 Reduced 36.25%	1,254 $11,000
Q4 2019 Feb 28, 2020	SELL	$9.73 - $19.31 $11,637 - $23,094	-1,196 Reduced 37.81%	1,967 $17,000
Q3 2019 Oct 15, 2019	SELL	$10.15 - $16.89 $9,683 - $16,113	-954 Reduced 23.17%	3,163 $33,000
Q2 2019 Jul 26, 2019	SELL	$14.6 - $20.6 $15,432 - $21,774	-1,057 Reduced 20.43%	4,117 $64,000
Q1 2019 Apr 19, 2019	BUY	$15.53 - $19.75 $18,729 - $23,818	1,206 Added 30.39%	5,174 $96,000
Q3 2018 Oct 31, 2018	BUY	$25.99 - $30.6 $9,720 - $11,444	374 Added 10.41%	3,968 $99,000
Q2 2018 Aug 14, 2018	BUY	$27.78 - $38.53 $25,002 - $34,677	900 Added 33.41%	3,594 $101,000
Q1 2018 May 23, 2018	BUY	$27.78 - $35.19 $74,839 - $94,801	2,694 New	2,694 $78,000

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

2.8K

Put Options Held

17.9K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$9.14 Million
0.35% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$3.66 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.85 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.85 Million
0.0% of portfolio
Baillie Gifford & CO

708K
Shares

$1.4 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $90.1M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.

Account